The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-(cyclopropanecarbonylamino)-4-[2-methoxy-3-[[4-(2-oxo-1-pyridyl)phenyl]carbamoyl]anilino]-N-(trideuteriomethyl)pyridazine-3-carboxamide ID: ALA5284638
Max Phase: Preclinical
Molecular Formula: C29H27N7O5
Molecular Weight: 553.58
Associated Items:
Names and Identifiers Canonical SMILES: [2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(C(=O)Nc2ccc(-n3ccccc3=O)cc2)c1OC
Standard InChI: InChI=1S/C29H27N7O5/c1-30-29(40)25-22(16-23(34-35-25)33-27(38)17-9-10-17)32-21-7-5-6-20(26(21)41-2)28(39)31-18-11-13-19(14-12-18)36-15-4-3-8-24(36)37/h3-8,11-17H,9-10H2,1-2H3,(H,30,40)(H,31,39)(H2,32,33,34,38)/i1D3
Standard InChI Key: ISZUIXXWPIZSBZ-FIBGUPNXSA-N
Molfile:
RDKit 2D
44 48 0 0 0 0 0 0 0 0999 V2000
-0.7134 1.3927 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0011 1.8050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7130 1.3932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7130 0.5679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0029 0.1562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7134 0.5642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0011 2.6303 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7135 3.0428 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.7158 3.0428 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.4303 2.6303 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4280 1.8053 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.1426 1.3927 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4280 0.1517 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.4280 -0.6734 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1452 3.0426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8573 2.6306 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8573 1.8052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1470 1.3933 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4303 1.8015 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5719 1.3926 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.1426 -1.0863 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1418 -1.9090 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.4270 -2.3217 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.7151 -1.9125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7103 -1.0878 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0005 -2.3251 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.8572 -0.6737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5719 -1.0863 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.8572 0.1514 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.2865 -0.6737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.0011 -1.0863 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
-4.2865 0.1514 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
-5.0011 -0.2611 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
4.2865 1.8052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0011 1.3926 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0011 0.5674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2865 0.1548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5719 0.5674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7141 -1.9125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7143 -1.0872 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.4318 -2.3268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8452 -3.0428 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2570 -2.3278 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8573 0.1548 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
2 7 1 0
7 8 2 0
7 9 1 0
9 10 1 0
1 11 1 0
11 12 1 0
6 13 1 0
13 14 1 0
15 10 2 0
16 15 1 0
17 16 2 0
18 17 1 0
19 18 2 0
10 19 1 0
17 20 1 0
21 14 2 0
22 21 1 0
23 22 2 0
24 23 1 0
25 24 2 0
14 25 1 0
24 26 1 0
21 27 1 0
27 28 1 0
27 29 2 0
28 30 1 0
30 31 1 0
30 32 1 0
30 33 1 0
34 20 1 0
35 34 2 0
36 35 1 0
37 36 2 0
38 37 1 0
20 38 1 0
26 39 1 0
40 39 2 0
39 41 1 0
42 41 1 0
42 43 1 0
41 43 1 0
38 44 2 0
M ISO 3 31 2 32 2 33 2
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 553.58Molecular Weight (Monoisotopic): 553.2074AlogP: 3.34#Rotatable Bonds: 9Polar Surface Area: 156.34Molecular Species: NEUTRALHBA: 9HBD: 4#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 4#RO5 Violations (Lipinski): 2CX Acidic pKa: 11.09CX Basic pKa: 3.35CX LogP: 3.45CX LogD: 3.45Aromatic Rings: 4Heavy Atoms: 41QED Weighted: 0.25Np Likeness Score: -1.43
References 1. Liu F, Wang B, Liu Y, Shi W, Hu Z, Chang X, Tang X, Zhang Y, Xu H, He Y.. (2023) Design, synthesis and biological evaluation of novel N-(methyl-d3 ) pyridazine-3-carboxamide derivatives as TYK2 inhibitors., 86 [PMID:36907336 ] [10.1016/j.bmcl.2023.129235 ]